Thorbald van Hall
机构: Professor experimental tumorimmunology
每年引用次数
引用次数
引用: 11,085
H-指数: 53
I10-指数 : 99
出版物: 176
Systemic Inflammatory Response Syndrome (SIRS) After Gp100 Peptide Vaccination for Intraocular Melanoma
M. J. B. van Stipdonk , M. J. Jager , G. P. M. Luyten , T. van Hall
Investigative Ophthalmology & Visual Science 50 ( 13) 6179 -6179
2009
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.
M. Gooden , M. Lampen , E. S. Jordanova , N. Leffers
Proceedings of the National Academy of Sciences of the United States of America 108 ( 26) 10656 -10661
122
2011
Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma.
P.J. de Vos van Steenwijk , T.H. Ramwadhdoebe , R. Goedemans , E.M. Doorduijn
International Journal of Cancer 133 ( 12) 2884 -2894
78
2013
The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment
M.A.C. Versluis , S. Marchal , A. Plat , G.H. de Bock
European Journal of Cancer 86 285 -295
29
2017
Joint-derived T cells in rheumatoid arthritis proliferate to antigens present in autologous synovial fluid.
M. M. Maurice , P. C. M. Res , A. Leow , T. van Hall
Scandinavian Journal of Rheumatology 101 169 -177
14
1995
Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity
N. van Montfoort , M. G. Camps , S. Khan , D. V. Filippov
Proceedings of the National Academy of Sciences of the United States of America 106 ( 16) 6730 -6735
126
2009
An immunodominant CTL epitope expressed by in vitro transformed cells is derived from plasmid vector backbone sequences
T. van Hall , N. van de Rhee , S. Schoenberger , M. Vierboom
Immunology Letters 56 455
1997
Teipp neoantigens and uses thereof
Thorbald Van Hall , Koen Mari Jt , Sjoerd Henricus An Der Burg
2019
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy
Elham Beyranvand Nejad , Camilla Labrie , Ziena Abdulrahman , Marit J van Elsas
Journal for ImmunoTherapy of Cancer 8 ( 2)
1
2020
Non-classical antigen presentation of tumor antigens enables CTL immunity to tumor escape variants
Thorbald Van Hall
Molecular Immunology 51 ( 1) 34
2012
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S
Tom J Harryvan , Marten Visser , Linda De Bruin , Léonie Plug
Journal for Immunotherapy of Cancer 10 ( 3)
6
2022
A novel inducible knockout mouse strain to study the impact of one-copy loss of HNRNPK in CD4 T cells as an experimental model of cutaneous lymphoma
Yixin Luo , Maarten Vermeer , Sanne De Haan , Frank De Gruijl
European Journal of Cancer 190 112993 -112993
2023
Regulatory T cell depletion using a CRISPR Fc-optimized CD25 antibody
Marit J Van Elsas , Johan MS Van der Schoot , Alexander Bartels , Kas Steuten
International Journal of Molecular Sciences 23 ( 15) 8707 -8707
4
2022
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy
Marit J van Elsas , Camilla Labrie , Anders Etzerodt , Pornpimol Charoentong
Journal for Immunotherapy of Cancer 11 ( 3)
6
2023
Methods for identifying t-cell epitopes associated with impaired peptide processing and applications of the identified epitopes
Thorbald Van Hall , Andreas Oliver Weinzierl , Petrus Antonius Van Veelen , Jan Wouter Drijfhout
3
2007
Cd94/nkg2a and/or cd94/nkg2b antibody, vaccine combinations
Sjoerd Van Der Burg , Thorbald Van Hall
10
2017
Teipp peptide variant and uses thereof
Thorbald Van Hall , Sjoerd Henricus Van Der Burg , Koen Marjit
2023
Antibody therapy
Hreinn Benonisson , Jim Middelburg , Thorbald Van Hall , Isil Altintas
2023
Tap-inhibitors from old world primate 1-herpesviruses and their use
Maaike Elisabeth Ressing , Daphne Van Leeuwen , Daniëlle HORST , Emmanuel Jacques Henri Joseph Wiertz
2009
Tumors with processing defects display novel tumor antigens via the non-classical HLA-E
Elien M Doorduijn , Claudia Cunha Oliveira , Bianca Querido , Marjolein Sluijter